Pacific Biosciences Of California (PACB) EBT Margin Growth (1y) (2011 - 2026)
Pacific Biosciences Of California (PACB) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 165.00 |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | -920.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -920.00 |
| Mar 31, 2026 | 112,586.00 |
| Dec 31, 2025 | -9,682.00 |
| Sep 30, 2025 | 5,408.00 |
| Jun 30, 2025 | 37,591.00 |
| Mar 31, 2025 | -94,619.00 |
| Dec 31, 2024 | 14,863.00 |
| Sep 30, 2024 | -1,264.00 |
| Jun 30, 2024 | -33,448.00 |
| Mar 31, 2024 | 2,482.00 |
| Dec 31, 2023 | 16,672.00 |
| Sep 30, 2023 | 9,892.00 |
| Jun 30, 2023 | 5,451.00 |
| Mar 31, 2023 | 1,942.00 |
| Dec 31, 2022 | -11,928.00 |
| Jun 30, 2022 | 8,680.00 |
| Mar 31, 2022 | -11,451.00 |
| Dec 31, 2021 | -46,536.00 |
| Jun 30, 2021 | 18,723.00 |
| Mar 31, 2021 | 8,450.00 |